Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $371.06 | 13 | 78.4% |
| Education | $102.37 | 3 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $113.50 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $107.11 | 4 | $0 (2019) |
| Relypsa, Inc. | $84.11 | 1 | $0 (2018) |
| Horizon Pharma plc | $39.67 | 1 | $0 (2017) |
| Aurinia Pharma U.S., Inc. | $37.76 | 2 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $24.61 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $22.04 | 1 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $16.56 | 1 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $14.81 | 1 | $0 (2024) |
| Amgen Inc. | $13.26 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.42 | 2 | AKEBIA THERAPEUTICS INC ($24.61) |
| 2023 | $37.76 | 2 | Aurinia Pharma U.S., Inc. ($37.76) |
| 2022 | $29.18 | 1 | AstraZeneca Pharmaceuticals LP ($29.18) |
| 2019 | $189.80 | 6 | Otsuka America Pharmaceutical, Inc. ($88.92) |
| 2018 | $102.30 | 2 | Relypsa, Inc. ($84.11) |
| 2017 | $74.97 | 3 | Horizon Pharma plc ($39.67) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 07/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Nephrology | ||||||
| 04/28/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/22/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/25/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.18 | General |
| 08/22/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.32 | General |
| 08/14/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 06/13/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 06/13/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEPHROLOGY | ||||||
| 01/31/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $16.56 | General |
| Category: NEPHROLOGY | ||||||
| 01/31/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEPHROLOGY | ||||||
| 11/15/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEPHROLOGY | ||||||
| 01/08/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $84.11 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2017 | Amgen Inc. | Sensipar (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Nephrology | ||||||
| 07/08/2017 | Astellas Pharma US Inc | Astagraf (Drug), Cresemba, Prograf | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 03/29/2017 | Horizon Pharma plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | Cash or cash equivalent | $39.67 | General |
| Category: RAYOS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,090 | 2,192 | $673,412 | $186,467 |
| 2022 | 13 | 1,155 | 2,191 | $666,246 | $180,719 |
| 2021 | 11 | 1,125 | 2,752 | $707,481 | $207,615 |
| 2020 | 13 | 1,205 | 2,898 | $893,445 | $233,794 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 32 | 189 | $179,550 | $48,417 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 193 | 598 | $95,082 | $34,405 | 36.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 97 | $92,150 | $20,707 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 288 | 402 | $59,496 | $17,734 | 29.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 145 | $32,770 | $12,764 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 210 | $48,930 | $11,620 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 104 | 115 | $36,915 | $10,800 | 29.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 16 | 41 | $38,950 | $8,931 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $22,656 | $6,468 | 28.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 42 | 91 | $33,215 | $4,795 | 14.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 68 | $10,200 | $2,380 | 23.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $8,064 | $2,324 | 28.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 62 | $7,130 | $2,138 | 30.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 37 | 54 | $5,184 | $1,983 | 38.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 14 | 27 | $2,160 | $785.97 | 36.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 13 | 16 | $960.00 | $213.44 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 199 | 606 | $96,354 | $31,789 | 33.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 36 | 130 | $123,500 | $28,817 | 23.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 31 | 79 | $75,050 | $20,031 | 26.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 15 | 84 | $79,800 | $18,454 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 286 | 395 | $58,460 | $17,387 | 29.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 108 | 119 | $53,312 | $17,106 | 32.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 82 | 222 | $50,172 | $16,817 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 223 | $51,959 | $12,869 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $15,744 | $5,089 | 32.3% |
About Dr. Saadia Khan, MD
Dr. Saadia Khan, MD is a Nephrology healthcare provider based in Lebanon, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902013410.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saadia Khan, MD has received a total of $473.43 in payments from pharmaceutical and medical device companies, with $39.42 received in 2024. These payments were reported across 16 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($371.06).
As a Medicare-enrolled provider, Khan has provided services to 4,575 Medicare beneficiaries, totaling 10,033 services with total Medicare billing of $808,594. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Lebanon, TN
- Active Since 05/16/2007
- Last Updated 01/10/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1902013410
Products in Payments
- Veltassa (Drug) $84.11
- SAMSCA (Drug) $74.13
- JYNARQUE (Drug) $49.54
- RAYOS (Drug) $39.67
- LUPKYNIS (Drug) $37.76
- Vafseo (Drug) $24.61
- Astagraf (Drug) $22.04
- TARPEYO (Drug) $14.81
- Sensipar (Drug) $13.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Lebanon
Elizabeth Brant, M.d, M.D
Nephrology — Payments: $1,611
Dr. Michael Chobanian, M.d, M.D
Nephrology — Payments: $1,180
Dr. Marios Prikis, M.d, M.D
Nephrology — Payments: $1,056
Bhabendra Putatunda, M.d, M.D
Nephrology — Payments: $136.63
Brian Remillard, Md, MD
Nephrology — Payments: $74.61
Jennifer Munson, M.d, M.D
Nephrology — Payments: $67.04